SMS Pharmaceuticals
SMSPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh Babu · MD: Ramesh Babu · Listing date: Feb. 28, 2007 · Employees: 1080 · Hyderabad · http://www.smspharma.com

Stock Price vs Company Growth
1d
6.6%
1w
2.5%
1m
2.0%
3m
60.3%
6m
73.7%
1y
144.6%
5y
30.6%
10y
22.3%
all
11.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 210 6.6%
129
219
Company Overview

Sales
613 Cr
Growth: 17.9%
Profit after Tax
38.8 Cr
Growth: 24.9%
Small Cap
1,775 Cr
P/E: 45.8x
Industry P/E: 34.5x
Fundamentals

Sales (Cr) ₹ 613
Growth 17.9%
EBITDA 17.3%
P/S 2.9x
Dividend 0.2%
P/E 45.8x
Book Value ₹ 58.2
PEG Ratio 2.6x
ROE 8.1%
P/B 3.6x
Shareholding Pattern

Institutions
Venkata Subbaraju Penmatsa .
2.13 %
Vivek Mundra
1.23 %
Aniruddh Mundra
1.13 %
Madhusudan Murlidhar Kela
1.1 %
Iepf
0.07 %
Promoters
Ramesh Babu Potluri
18.37 %
Hima Bindu Potluri
17.47 %
Vamsi Krishna Potluri
15.74 %
Potluri Infra Projects Llp
8.68 %
Trilok Potluri
2.58 %
Others
Increase    Decrease    No change
Company Profile Detailed

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base.
Investors (44)